A peptide dosage chart, one peptide at a time: its dose range, how often it’s taken, a typical run and the units on your syringe. All 69 peptides in the PepVault library.
A community reference, not medical advice. Each range is what has been studied or is commonly run, never a dose for you.
The first triple agonist to reach phase 3: it activates GLP-1, GIP and glucagon receptors at once, and the glucagon arm adds extra calorie burn (shown in mice). Commonly reported: appetite suppression even stronger than tirzepatide, GI side effects after each step-up, and a higher resting heart rate. Its top dose averaged about 25–28% weight loss at 80 weeks in phase 3; it isn't approved yet.
With a 10 mg vial and 2 mL of water (5 mg in every mL), on a 1 mL (100-unit) U-100 insulin syringe: the low end, 1 mg, is 20 units; the start, 2 mg, is 40 units; and the high end, 12 mg, needs more than this vial holds. 10 doses in the vial at the low end. All U-100: 100 units to the mL. A U-40 syringe reads differently.
Retatrutide week by weekWhat to take alongside each peptideRetatrutide in the peptide libraryThe Dose Guide: every peptide
Newsletter · Weekly
New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.
PepVault logs every dose, keeps count of the doses left in your vials, and reminds you on your schedule.
Get PepVault on the App Store7 days free on the yearly plan for new subscribers.
A community reference, not medical advice. Each range is what has been studied or is commonly run, never a dose for you.
Newsletter · Weekly
New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.